Cargando…
Substance Abuse Disorders : Evidence and Experience.
Substance abuse disorders are among the most prevalent psychiatric disorders and are frequently comorbid with other psychiatric and health conditions and accompanied by social problems; however, they remain under-recognized and under-treated. Many physicians and mental health practitioners receive l...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Otros Autores: | , , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Hoboken :
John Wiley & Sons,
2011.
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Cover; Series; Title Page; Copyright; List of Contributors; Preface; Section 1: Drugs; Chapter 1: Epidemiology of Drug Abuse: A Global Overview; 1.1 INTRODUCTION; 1.2 THE CASE OF VULNERABILITY POPULATIONS; 1.3 DISCUSSION AND CONCLUSIONS; Chapter 2: Drug Abuse: Prevention; 2.1 INTRODUCTION; 2.2 HEALTH AND SOCIAL CONSEQUENCES OF DRUG USE AND DRUG-ATTRIBUTABLE BURDEN; 2.3 TARGETS FOR PREVENTION; 2.4 REDUCING THE BURDEN ATTRIBUTABLE TO DRUG USE; 2.5 TRAJECTORIES OF DRUG USE: PRIMARY, SECONDARY AND TERTIARY PREVENTION; 2.6 PREVENTIVE INTERVENTIONS: UNIVERSAL, SELECTIVE AND INDICATED.
- 2.7 levels of interventions2.8 principles for drug prevention; 2.9 evidence on effectiveness of prevention interventions; 2.10 control of availability of drugs and judicial procedures; 2.11 mass media interventions; 2.12 prevention programs with short-term and long-term effects on drug use; 2.13 interventions with short-term follow-up (up to 1 year); 2.14 interventions with medium-term follow-up (from 1 to 3 years); 2.15 interventions with long-term follow-up (3+ years); 2.16 interventions with evidence of little or no effectiveness.
- 2.17 CONTENT AND DESIGN OF PROGRAMS WITH EVIDENCE OF EFFECTIVENESS2.18 EXPERIMENTAL TECHNIQUES; 2.19 ROLE OF HEALTH-CARE PROFESSIONALS IN PREVENTION OF DRUG USE AND DRUG-USE DISORDERS; Chapter 3: Drug Abuse: Treatment and Management; 3.1 INTRODUCTION; 3.2 PHARMACOLOGICAL MANAGEMENT OF OPIATE MISUSE; METHADONE; 3.3 PHARMACOLOGICAL MANAGEMENT OF OPIATE MISUSE; BUPRENORPHINE; 3.4 PHARMACOLOGICAL MANAGEMENT OF OPIATE MISUSE; NALTREXONE; 3.5 STIMULANTS (COCAINE; AMPHETAMINE AND METHAMPHETAMINE; ECSTASY AND ECSTASY-LIKE DRUGS); 3.6 PHARMACOLOGICAL MANAGEMENT OF BENZODIAZEPINE MISUSE.
- 3.7 REVIEW OF MOST RECENT LITERATURE ON THE ROLE OF PSYCHOSOCIAL INTERVENTION IN THE TREATMENT AND MANAGEMENT OF SUBSTANCE MISUSE3.8 DISCUSSION AND CONCLUSIONS; Chapter : 4.1 Measuring, Preventing and Treating Global Drug Abuse; CULTURAL DIVERSITY AND ECONOMIC DISPARITY; REDUCING SUPPLY, DEMAND AND HARM; TREATMENT AND MANAGEMENT STRATEGIES; CHANGING TRENDS IN DRUG MISUSE AND IN TREATMENT; SUMMARY; Chapter : 4.2 Epidemiology, Treatment and Prevention of Addictive Disorders; Chapter : 4.3 The Global Challenge of Illegal Drugs; INTRODUCTION.
- Chapter : 4.4 Drug Misuse
- Lessons Learned Through the Modern ScienceChapter : 4.5 An Integrated Approach to Drug-Abuse Treatment: The Role of Prevention; Chapter : 4.6 Informing the Field of Substance Misuse: Progress and Challenges; Section 2: Alcohol; Chapter 5: Epidemiology of Alcohol Abuse: Extent and Nature of the Problem; 5.1 INTRODUCTION; 5.2 METHODS; 5.3 RESULTS; 5.4 DISCUSSION; 5.5 ACKNOWLEDGEMENTS; Chapter 6: The Prevention of Alcohol Problems; 6.1 INTRODUCTION; 6.2 THE IMPACT OF ALCOHOL ON HEALTH; 6.3 ALCOHOL CONSUMPTION IN THE COMMUNITY; 6.4 APPROACHES TO PREVENTION.